blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1

This blog is brougt to you consistent with subsection 3 of the Protection from Harassment Act - i.e. blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1



Friday, 19 March 2010

Seroxat USER group expert witness was paid consultant to GSK


http://bjp.rcpsych.org/cgi/reprint/180/6/547.pdf

Prof Healy is a paid consultant for GSK, Pfizer & a number of other pharmaceutical companies




Correspondence


by D Healy - 2002 - Related articles



 
http://bjp.rcpsych.org/cgi/reprint/180/6/547.pdf

PPH Diet Drug Wrongful Death Trial Settles for $10 million - source BNET

.The first diet drug wrongful death trial involving primary pulmonary hypertension (PPH) ended Jan. 27 with a reported $10 million settlement by American Home Products Corp. (AHP) (Thomas F. Linnen, et al. v. A.H. Robins Co. Inc., et al., No. 97-2307, Mass. Super., Middlesex Co.).


http://findarticles.com/p/articles/mi_pwwi/is_20050229/ai_mark13005453/?tag=content;col1

Besides being the first wrongful death PPH case to go to trial, the case of Mary J. Linnen is noteworthy because she used fen-phen for only 24 days, because jurors were allowed to asked written questions of witnesses, because it was disclosed that AHP indemnified the prescribing doctor and because AHP's general counsel personally intervened six days into the plaintiff's case and negotiated a settlement.




Linen's parents, Thomas F. and Mary J., sued AHP subsidiaries A.H. Robins and Wyeth-Ayerst Laboratories Inc., phentermine manufacturer Fisons Corp., prescribing physician Dr. Abby Landzberg, Walgreens pharmacy and pharmacist Robert Blake. They say that Linnen, 30, wanted to lose 30 pounds for her upcoming wedding and Landzberg prescribed fen-phen in April 1996. Linnen stood 5-foot-5-inches tall and weighed 185 pounds and was reported to be in excellent health when she began taking the drugs.



Eleven days after starting the regimen, Linnen began experiencing heart palpitations and shortness of breath and the drugs were discontinued on Landzberg's orders.



Linnen was later diagnosed with PPH and died in February 1997 of the disease.



Fisons was dismissed last month after Judge Raymond Brassard of the Massachusetts Superior Court for Middlesex County disqualified plaintiff phentermine experts Drs. Paul Wellman and Alan Woolf. Walgreen settled before trial.



The AHP subsidiaries and Landzberg remained the only defendants when testimony began Jan. 18.

Thursday, 18 March 2010

Scientology award to Fiddaman's publisher Chipmunka's Jason Pegler

Jason Pegler, chief executive of the mental health publisher Chipmunka Publishing, was also honoured for exposing an abusive mental health system through the publication of books written by those caught up in a system where their stories would otherwise go unheard. A psychiatric survivor himself, Pegler realised a ‘healing process’ by writing about his experiences, and has gone on to encourage others to do the same, publishing over 50 titles.



 http://www.pr-inside.com/three-human-rights-awards-presented-by-r105271.htm

Saturday, 13 March 2010

AZ falls foul of ABPI Code of Practice with Seroquel ad

AZ falls foul of ABPI Code of Practice with Seroquel ad


http://www.pharmatimes.com/UKNews/article.aspx?id=17534

10 March 2010

A preliminary ruling by the Prescription Medicines Code of Practice Authority says AstraZeneca broke advertising rules by failing to accurately reflect the side-effects of its antipsychotic Seroquel.



The policing arm of the Association of the British Pharmaceutical Industry has allegedly found the Anglo-Swiss drugmaker to be in breach of the Code on three counts, with claims made in an ad – published in the British Journal of Psychiatry in 2004 - that Seroquel (quetiapine) has a favourable weight profile compared with rival drugs, according to media reports.



Because weight gain is in fact a fairly common side effect of Seroquel, the PMCPA ruled that the company’s ad was misleading and had breached ethical code requirements that marketing information should be “accurate and fair, and be capable of substantiation”, according to the Financial Times.



A spokeswoman for the PMCPA could not divulge any details regarding the ruling, as, she stressed, the information is only intended for full disclosure when a final decision is reached, and should not have been made public at this point.



However, she was able to confirm to PharmaTimes UK News that the PMCPA received three separate complaints regarding AZ’s promotion of Seroquel in January – one from a healthcare professional, one from a journalist and one from a member of the public – and that letters regarding the initial ruling on these cases had been sent out on Monday, allowing the claimants and AZ until the end of the week to lodge any appeals.



In defence, AZ is arguing that the intended audience for the advert would have understood that the information was in fact claiming that while Seroquel did result in weight gain, its profile was still favourable to other antipsychotics on the market at that time. "The intended audience for the advertisement was UK healthcare professionals, including UK specialist psychiatrists who we believe would have understood the statement in the broader context of the debate around weight gain and atypical antipsychotics in UK" the company said in an emailed statement to PharmaTimes.



Furthermore, AZ said it has long worked with regulatory authorities “to ensure that the safety profile of Seroquel is reflected appropriately in the label so that doctors can weigh the risks and benefits of medicines when making treatment decisions”, and that when Seroquel was first cleared for use in the UK, “the label alerted physicians that ‘weight gain’ had been observed”.



Misleading claims?

However, earlier this year a former employee of AZ has told the BBC he was pressured by the firm’s marketeers to approve claims that Seroquel was not linked with weight gain, despite evidence to the contrary.



John Blenkinsopp, the company's former UK medical manager, told the BBC Radio 4’s File on 4 programme that, while clinical studies at the time Seroquel’s launch “showed patients developed significant weight gain, significant both statistically and clinically”, the company’s marketing team “came at me with a number of potential claims all of which were trying to intimate that Seroquel was not associated with weight gain”.



Launched in 1997 for the treatment of schizophrenia and later bipolar disorder, Seroquel quickly became one of the world’s top 10 selling drugs and, with annual sales of around $4.45 billion a year, AZ’s second-biggest earner.



News of the ruling will likely come as a bitter blow to the firm, which is currently battling thousands of lawsuits in the US alleging that it withheld information and failed to adequately warn patients of Seroquel’s side effects such as significant weight gain and an increased risk of diabetes.



A spokesperson for AZ could not comment on the ruling but told PharmaTimes UK News that the company was still examining the PMCPA's decision in detail, before deciding on whether or not to lodge an appeal.



By Selina McKee

Seroxat "has made me a danger" - Bob Fiddaman states in letter to Sunday Mercury

Letter: Drug has made me a danger
Sunday Mercury (Birmingham, England), June 27, 2004


I READ with great interest the story of Faye Elliot from Gloucestershire regarding her plight with the antidepressant Seroxat. I, like Faye, am part of the Online Seroxat Support Group and have had horrendous side-effects from this so-called 'wonder drug'.


Fortunately, I am now Seroxat-free, coming off the drug 'cold turkey' over four months ago. This was my fourth attempt to come off after being prescribed them by my GP over six years ago.

During those six years, I made one suicide attempt, separated from my wife and three children and lost my job. The effects have had a devastating effect on my life.

Seroxat has changed me as a person -I no longer wish to be in social situations because I fear for the safety of whoever says the wrong thing to me.

A lot of my anger is vented toward the company that manufacture the drug, Glaxo SmithKlein (GSK), for their lies and deceit on the general public.

This anti-depressant should be banned immediately whilst there is a public inquiry.

The frustration and anger inside me grow each day, particularly recently as there have been many stories regarding people's struggles with this demon drug.

I do not blame the GPs or psychiatrists -they have been kept as much in the dark as the patients. Something needs to be done and it needs to be seen to be done with immediate effect otherwise there will be more stories of suicide or homicidal tendencies.

I hope one day that the powers-that-be at GSK and the Medicines and Healthcare products Regulatory Agency (MHRA), a board set up to grant licences to pharmaceu-tical companies, are force-fed this drug for a six-week period -then taken off it. Let's see them suffer the electric-like zaps through the body, the profuse sweating, the bouts of insomnia, the bouts of parasomnia, the rage and fury. Let them lose their wife and kids, their job, their friends, their sanity.

I applaud the Sunday Mercury for shedding light on this matter.

The Online Seroxat Support Group can be contacted via fiddaman64@blueyonder.co.uk

BOB FIDDAMAN Quinton Birmingham

http://findarticles.com/p/news-articles/sunday-mercury-birmingham-england/mi_7995/is_2004_June_27/letter-drug-danger/ai_n37255173/

Fluoxetine: possible small risk of congenital cardiac defects - MHRA pdf




Friday, 12 March 2010

Seroxat & Prozac birth defects rate similar - MHRA

The agency said it had looked at the evidence from a number of studies of fluoxetine, the active ingredient in Prozac, and concluded that it could double the background rate of congenital heart defects.


http://bobfiddaman.blogspot.com/2010/03/pregnant-women-warned-over-prozac-risk.html


About one in 100 babies are typically born with a problem such as a heart murmur, hole in the heart or other problem with the organ’s structure or rhythm.



But the MHRA estimates this rate increases to almost two in 100 pregnancies among women prescribed fluoxetine, which is a similar rate to another common antidepressant, Seroxat (paroxetine).



The drugs are part of a group known as selective serotonin reuptake inhibitors (SSRIs), which are not recommended to be taken during pregnancy because of the risk of withdrawal symptoms in the developing baby.

Pregnant women warned over Prozac risk to foetus - Times Online

Pregnant women warned over Prozac risk to foetus - Times Online: "Pregnant women warned over Prozac risk to foetus"

Pregnant women who take Prozac, the antidepressant, are twice as likely to give birth to babies with a congenital heart problem, the medicines regulator has warned.

The Medicines and Healthcare products Regulatory Agency (MHRA) said there was a “possible small risk” of congenital heart defects if women were given the drug in early pregnancy.

The agency said it had looked at the evidence from a number of studies of fluoxetine, the active ingredient in Prozac, and concluded that it could double the background rate of congenital heart defects.

About one in 100 babies are typically born with a problem such as a heart murmur, hole in the heart or other problem with the organ’s structure or rhythm.

But the MHRA estimates this rate increases to almost two in 100 pregnancies among women prescribed fluoxetine, which is a similar rate to another common antidepressant, Seroxat (paroxetine).

The drugs are part of a group known as selective serotonin reuptake inhibitors (SSRIs), which are not recommended to be taken during pregnancy because of the risk of withdrawal symptoms in the developing baby.

But it is estimated that 2.3 per cent of pregnant women each year are prescribed SSRIs when the benefits are considered to outweigh the risks.

Studies suggest that up to one in five mothers-to-be suffer from depression at some point during pregnancy, which if left untreated can cause low birth weight and premature birth.

The MHRA said that a class effect with SSRIs on heart formation in utero “could not be excluded” and recommended GPs were mindful of this when prescribing the drugs.

The agency said: “When prescribing fluoxetine to treat depression during pregnancy, prescribers should be aware that there may be a small increased risk of congenital cardiac defects in infants exposed in early pregnancy, similar to that seen with paroxetine.”

Letter: Drug has made me a danger

http://findarticles.com/p/news-articles/sunday-mercury-birmingham-england/mi_7995/is_2004_June_27/letter-drug-danger/ai_n37255173/

read on -

Thursday, 11 March 2010

Healy withdrawal protocol fails 98% of time - paxilprogress

Seroxat USERS collaborate with MHRA Expert Working Group

10.3 The Group was informed that the Seroxat Users Group, which is a UK patient support group, has been in correspondence with the MHRA and its predecessor the Medicines Control Agency expressing its concerns about the safety of paroxetine. The MHRA had informed the Seroxat Users Group of its willingness to consider any reports of suspected adverse drug reactions submitted by members of the Seroxat User Group. In recent correspondence the Seroxat Users Group has expressed an interest in meeting with the Expert Group in order to contribute to its work.


10.4 The Expert Group commented that the views of the Seroxat User Group would provide a valuable contribution to the ongoing review. It was agreed that the Seroxat

 
Users Group should be given the opportunity to make a presentation to the Group should they wish. However, they might prefer a less formal meeting between representatives of the Expert Group and members of the MHRA to discuss their concerns. It was agreed that it would be helpful if the Seroxat Users Group provided a written representation which could then be considered by the Group.
http://www.mhra.gov.uk/home/groups/pl-p/documents/committeedocument/con003485.pdf

Sunday, 7 March 2010

Seroxat Sock Puppet Mark Harvey tells GSK don't accept liability just change the P.I.L.

http://groups.yahoo.com/group/uksurvivors/message/12365


http://www.hjfs.co.uk/images/partners/Mark%20Harvey.jpg



The chemistry of happiness , located @

http://www.seroxatusergroup.org.uk/media_interest.htm





Harvey is not the sort of hot-headed litigator we may be familiar

with from the movies; he does not distrust Big Medicine per se.



~~~~and he has a moderate suggestion 'If [GSK] were sensible, they

would sit down and go, "We don't accept any legal liability but we

recognise that we could improve the information that we give to the

patient and the doctor."'





The chemistry of happiness , also located @

http://society.guardian.co.uk/mentalhealth/story/0,8150,707016,00.htm

Cold Case Files - Paxil Birth Defects - sponsored by ads Scientology

Wednesday, 3 March 2010

BBC checking out Seroxat's Shelley Jofre yet again !

IP Address 132.185.240.124

ISP BRITISH BROADCASTING CORPORATION

Domain BBC.CO.UK

City LONDON

Region ENGLAND

Country UNITED KINGDOM

Returning Visits 4

Date Time WebPage

March 03, 2010 9:09:47 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: Shelley Jofre who failed expectant mothers everywhere, she knew there was a problem with all SSRI, but only researched Seroxat to meet the requirements Seroxat lawyer Mark Harvey

http://bobfiddaman.blogspot.com/2010/01/shelley-jofre-who-failed-expectant.html

http://www.google.co.uk/search?q=shelley%20jofre&hl=en&sa=N&tab=bw

March 03, 2010 9:09:04 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: uksurvivors : Message: Shelley Jofre Panorama programme removed after complaint

http://bobfiddaman.blogspot.com/2010/02/uksurvivors-message-shelley-jofre.html

http://blogsearch.google.co.uk/blogsearch?q=shelley%20jofre&hl=en&tab=nb

February 26, 2010 8:48:34 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: uksurvivors : Message: Shelley Jofre Panorama programme removed after complaint

http://bobfiddaman.blogspot.com/2010/02/uksurvivors-message-shelley-jofre.html

http://www.google.co.uk/search?tbo=1&tbs=blg%3A1&q=shelley%20jofre&hl=en&ie=UTF- 8&tab=nb

Monday, 1 March 2010

Spitzer only wanted a trial data web site - not Paxil sales restriction

extract from - http://bostonreview.net/BR35.2/spitzer.php


When we sued Glaxo, they thought we wanted money. But we only wanted them to change the way they acted. We asked them to create a Web site for the clinical testing data so that doctors and journals could make informed judgments. They agreed. The settlement became part of a longer process, a move toward substantially more disclosure when it comes to drugs and testing data.



From Glaxo’s perspective, the more data they withheld, the better it was for them. They could persuade more people to use Paxil. So, again: only government can ensure integrity, transparency, and fair dealing.

NOT for Spitzer to decide if Paxil was good/bad for teenagers - the case was about disclosure of information

extract from - http://bostonreview.net/BR35.2/spitzer.php


Here’s another story. We brought a case against GlaxoSmithKline, which was at the time marketing Paxil—an anti-depressant—as effective for teenagers. It had been approved for other purposes, but this was off-label marketing. We found that a significant number of the clinical tests they had done proved something directly at odds with their claims. It was not for me as attorney general to determine whether this drug was bad or good for teenagers, but to insist on full disclosure of critically relevant information so that doctors and journals could make that determination.




When we sued Glaxo, they thought we wanted money. But we only wanted them to change the way they acted. We asked them to create a Web site for the clinical testing data so that doctors and journals could make informed judgments. They agreed. The settlement became part of a longer process, a move toward substantially more disclosure when it comes to drugs and testing data.



From Glaxo’s perspective, the more data they withheld, the better it was for them. They could persuade more people to use Paxil. So, again: only government can ensure integrity, transparency, and fair dealing.

Eliot Spitzer: The Rules - Government’s proper role in the market

Boston Review — Eliot Spitzer: The Rules


Eliot Spitzer




Every day we read the headlines, feel the tensions, observe the consequences of the recent failures of market and government. Having a serious conversation about how to remedy these failures lies at the heart of current American politics. And that conversation should address three distinct questions:



• What are the parameters of government intervention in the marketplace? What rules should we use in deciding when the government should act, and when it should let the market take its course?

read on -


http://bostonreview.net/BR35.2/spitzer.php

An Overdose at 15 - Traci Johnson / Tylenol (paracetamol)?

An Overdose at 15




Johnson seemed like a good candidate for the duloxetine trial. At 5-foot-4 and 130 pounds, she was physically fit and, by all accounts, reliable and upbeat.



But during her interview, she told screeners that when she was 15, she had landed in the emergency room after overdosing on Tylenol pills and had to have her stomach cleared, according to a psychiatrist studying duloxetine who has read a report on Johnson's case. The doctor spoke on condition of anonymity because the information was considered confidential

http://66.102.9.132/search?q=cache:XZTbVB6fKjAJ:articles.latimes.com/2004/apr/02/science/sci-humantest2+%22A+Godsend,+Till+a+Life+Unravels%22&cd=1&hl=en&ct=clnk

A Godsend, Till a Life Unravels - Los Angeles Times

A Godsend, Till a Life Unravels - Los Angeles Times: "A Godsend, Till a Life Unravels"

Traci Johnson joined a clinical trial of an antidepressant to pay for college. The devout woman ended up taking her own life.


THE NATION
COLUMN ONEApril 02, 2004
Alan Zarembo and Benedict Carey , Times Staff WritersINDIANAPOLIS — Traci Johnson believed it was God's plan for her to leave home to attend a tiny Bible college here -- and she prayed every day for the Lord to provide for her tuition.



Then an unusual opportunity presented itself.

read on - http://articles.latimes.com/2004/apr/02/science/sci-humantest2

justAna: People close to Trace Johnson left three comments anonymously

justAna: People close to Trace Johnson left three comments anonymously

I received three comments of someone or more than one person that claims they mourn Traci's death and was very close to her. These are the comments:






melissa said...

I just wanted to comment here, that I too remember dearest Tracy. I was all too close to her this very night that she passed and my prayers continue for her family that survived her passing. Now 6 years later and my heart still bleeds a bit as we pass by this season of life again and mourn her loss.



With Love,

-Someone who was Called to the scene of passing-



February 14, 2010 6:25 PM









This one at this post and:





AnnaJ said...

I knew Traci. What a loss! We still carry the pain and sadness of her absence from our lives.



February 27, 2010 3:16 PM



Anonymous said...

Thank you for honoring Traci. She is sorely missed. We knew Traci. She was a part of our lives. The sheer devistation has not healed even after 7 years. We are still suffering from the absence of this wonderful person in our lives.



February 27, 2010 3:23 PM



these at my other blog here.



Thank you for leaving these messages but I will never understand why people who are close to Traci Johnson says nothing, keep in silence and don't fight for justice to what was done to this 19 years-old healthy girl who was murdered at Eli-Lilly's facilities after taking Cymbalta and having as side effect drug-induced suicidal ideation. She hanged herself but keep in mind that she was not testing Cymbalta as an antidepressant but as a medicine for urinary incontinence and that she has never had any kind of mental disease since it was one of the requirements to be a volunteer in that clinical trial. Eli-Lilly wanted healthy people for this clinical trial and Traci Johnson was accepted after being examined and classified as not having any kind of mental disease. We are talking about a girl who just volunteered to a clinical trial because her father was jobless and she was going to be paid $ 150 a day.



I don't understand why these people are commenting anonymously and since I started bloging I asked many people if they knew about Traci Johnson's parents, relatives or friends.





If you keep on silent and don't fight for justice like Sara Carlin's parents and others I have to admit that I have to believe in those who claim that Elli Lilly has payed the family to keep silent.



Unacceptable.